Hypertrophic cardiomyopathy as a cause of sudden death

Herz

Volumn 34, Issue 4, 2009, Pages 305-314

  Seggewiss, Hubert ^a   Blank, Christoph ^a   Pfeiffer, Barbara ^a   Rigopoulos, Angelos ^b  

^a Leopoldina Krankenhaus   (Germany)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Athlete's heart; Hypertrophic cardiomyopathy; Preparticipation screening; Prevention; Sudden death; Young athlete

Indexed keywords

ATHLETE; CAUSE OF DEATH; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HISTORY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; PATHOPHYSIOLOGY; PRESSOR RESPONSE; REVIEW; RISK ASSESSMENT; SCREENING TEST; SPORT; SUDDEN DEATH; SYNCOPE;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HUMANS; SPORTS;

EID: 67650774057     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3248-z     Document Type: Review

References (60)

1. B.J. Maron 2002 Hypertrophic cardiomyopathy: a systematic review JAMA 287 1308 20
2. P. Elliott W.J. McKenna 2004 Hypertrophic cardiomyopathy Lancet 363 1881 91
3. D. Teare 1958 Asymmetrical hypertrophy of the heart in young adults Br Heart J 20 1 8
4. E. Braunwald C.T. Lambrew S.D. Rockoff 1964 Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients Circulation 30 Suppl4 3 119
5. W. McKenna J. Deanfield A. Faruqui 1981 Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features Am J Cardiol 47 532 8
6. B.J. Maron P. Spirito 1993 Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history Am J Cardiol 72 970 2
7. R.J. Myerburg K.M. Kessler A.L. Bassett 1989 A biological approach to sudden cardiac death: structure, function and cause Am J Cardiol 63 1512 6
8. B.J. Maron W.K. Shen M.S. Link 2000 Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 365 73
9. A.S. Adabag B.J. Maron 2007 Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy Ann Noninvasive Electrocardiol 12 171 80
10. P.O. Lim J.A. Morris-Thurgood M.P. Frenneaux 2002 Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise Cardiol Rev 10 15 23 (Pubitemid 34130765)
11. P. Nicod R. Polikar K.L. Peterson 1988 Hypertrophic cardiomyopathy and sudden death N Engl J Med 318 1255 7
12. B.J. Maron W.C. Roberts S.E. Epstein 1982 Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients Circulation 65 1388 94
13. N. Sadoul K. Prasad P.M. Elliott 1997 Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy Circulation 96 2987 91
14. K. Prasad L. Williams R. Campbell 2008 Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation Heart 94 1312 7
15. A.L. Mark J.M. Kioschos F.M. Abboud 1973 Abnormal vascular responses to exercise in patients with aortic stenosis J Clin Invest 52 1138 46
16. D. Corrado C. Basso G. Rizzoli 2003 Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42 1959 63
17. B.J. Maron J. Shirani L.C. Poliac 1996 Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles JAMA 276 199 204 (Pubitemid 26235063)
18. B.J. Maron 2003 Sudden death in young athletes N Engl J Med 349 1064 75
19. S. Sack 2004 Sports death - an internal medicine problem? Herz 29 414 9
20. B.J. Maron S.E. Epstein W.C. Roberts 1986 Causes of sudden death in competitive athletes J Am Coll Cardiol 7 204 14
21. B.J. Maron W.C. Roberts H.A. McAllister 1980 Sudden death in young athletes Circulation 62 218 29
22. D. Corrado C. Basso M. Schiavon 1998 Screening for hypertrophic cardiomyopathy in young athletes N Engl J Med 339 364 9
23. B.J. Maron T.E. Gohman D. Aeppli 1998 Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes J Am Coll Cardiol 32 1881 4
24. B.J. Maron J.J. Doerer T.S. Haas 2009 Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006 Circulation 119 1085 92
25. B.J. Maron K.P. Carney H.M. Lever 2003 Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy J Am Coll Cardiol 41 974 80
26. B.J. Maron A. Pelliccia 2006 The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death Circulation 114 1633 44
27. B.J. Maron J.M. Isner W.J. McKenna 1994 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse J Am Coll Cardiol 24 880 5
28. A. Pelliccia D.P. Zipes B.J. Maron 2008 Bethesda Conference #36 and the European Society of Cardiology consensus recommendations revisited: a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities J Am Coll Cardiol 52 1990 6
29. B.J. Maron P.D. Thompson J.C. Puffer 1996 Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association Circulation 94 850 6
30. D.W. Glover B.J. Maron 1998 Profile of preparticipation cardiovascular screening for high school athletes JAMA 279 1817 9
31. G.C. Pfister J.C. Puffer B.J. Maron 2000 Preparticipation cardiovascular screening for US collegiate student-athletes JAMA 283 1597 9
32. D. Corrado A. Pelliccia H.H. Bjornstad 2005 Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 516 24
33. B.J. Maron J.M. Gardin J.M. Flack 1995 Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults Circulation 92 785 9
34. A. Pelliccia F.M. Di Paolo D. Corrado 2006 Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes Eur Heart J 27 2196 200
35. D. Corrado C. Basso A. Pavei 2006 Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program JAMA 296 1593 601
36. B.J. Maron P.D. Thompson M.J. Ackerman 2007 Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation Circulation 115 1643 55
37. S. Basavarajaiah M. Wilson G. Whyte 2008 Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening J Am Coll Cardiol 51 1033 9
38. L. Faber F. van Buuren 2008 Athlete screening for occult cardiac disease: no risk, no fun? J Am Coll Cardiol 51 1040 1
39. T.W. Rowland 2005 Evaluating cardiac symptoms in the athlete: is it safe to play? Clin J Sport Med 15 417 20
40. B.J. Maron 1986 Structural features of the athlete heart as defined by echocardiography J Am Coll Cardiol 7 190 203 (Pubitemid 16132478)
41. B.J. Maron A. Pelliccia P. Spirito 1995 Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy Circulation 91 1596 601
42. A. Pelliccia B.J. Maron A. Spataro 1991 The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes N Engl J Med 324 295 301
43. A. Pelliccia D. Corrado H.H. Bjornstad 2006 Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis Eur J Cardiovasc Prev Rehabil 13 876 85
44. S. Sharma P.M. Elliott G. Whyte 2000 Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes J Am Coll Cardiol 36 864 70
45. A. Anastasakis C. Kotsiopoulou A. Rigopoulos 2005 Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes Heart 91 1477 8
46. A.A. Ehsani J.M. Hagberg R.C. Hickson 1978 Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning Am J Cardiol 42 52 6
47. A. D'Andrea L. D'Andrea P. Caso 2006 The usefulness of Doppler myocardial imaging in the study of the athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy Echocardiography 23 149 57
48. T. Scheffold P. Binner J. Erdmann 2005 Hypertrophic cardiomyopathy Herz 30 550 7
49. J.C. Moon W.J. McKenna J.A. McCrohon 2003 Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 1561 7
50. M. Vohringer H. Mahrholdt A. Yilmaz 2007 Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR) Herz 32 129 37
51. P.M. Elliott J. Poloniecki S. Dickie 2000 Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2212 8
52. B.J. Maron P. Spirito W.K. Shen 2007 Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 405 12
53. D.P. Zipes A.J. Camm M. Borggrefe 2006 ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur Heart J 27 2099 140
54. L. Monserrat P.M. Elliott J.R. Gimeno 2003 Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients J Am Coll Cardiol 42 873 9
55. P. Elliott P. Spirito 2008 Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice Heart 94 1269 75
56. J.A. Drezner R.W. Courson W.O. Roberts 2007 Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement Heart Rhythm 4 549 65
57. J.H. Mitchell W. Haskell P. Snell 2005 Task Force 8: classification of sports J Am Coll Cardiol 45 1364 7
58. I. Olivotto B.J. Maron F. Cecchi 2001 Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy Curr Cardiol Rep 3 141 6
59. M.S. Maron I. Olivotto S. Betocchi 2003 Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 295 303 (Pubitemid 36119984)
60. P.M. Elliott J.R. Gimeno M.T. Tome 2006 Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy Eur Heart J 27 1933 41